Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

NCT01329185 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

EBV Viremia
CMV Viremia

Interventions

DRUG: Valganciclovir
DRUG: Placebo

Sponsor

University of Minnesota